Literature DB >> 1832266

Organic cation transport in human renal brush-border membrane vesicles.

R J Ott1, A C Hui, G Yuan, K M Giacomini.   

Abstract

The renal proximal tubule is responsible for the active elimination of organic cations. Studies in brush-border membrane vesicles (BBMV) suggest that active organic cation transport is mediated by an organic cation-proton antiporter. The goals of this study were to determine whether this transporter is expressed in human kidney and to elucidate its characteristics. Transport of the organic cations N1-[3H]methylnicotinamide (NMN) and [14C]tetraethylammonium (TEA) was determined by rapid filtration in BBMV of donor human kidneys. The uptake of NMN and TEA was driven against a concentration gradient by an outwardly directed proton gradient. NMN uptake was inhibited by the organic cations TEA, NMN, quinine, and cimetidine, but was not affected by p-aminohippuric acid, cephalexin, and polyamines. The electroneutral transport of NMN was characterized by a Km of 0.44 +/- 0.07 mM and a Vmax of 24.4 +/- 15.2 pmol.mg protein-1.s-1. The rate of proton efflux from BBMV increased in the presence of an inwardly directed TEA gradient. Preloading BBMV with NMN or TEA trans-stimulated the initial rate of uptake of TEA. Therefore the human proximal tubule expresses an organic cation-proton antiporter in the brush-border membrane. The antiporter is similar to that described in other mammalian species but shows some differences in its transport characteristics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832266     DOI: 10.1152/ajprenal.1991.261.3.F443

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

Review 2.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

3.  Guanidine transport in a human choriocarcinoma cell line (JAR).

Authors:  S Zevin; M E Schaner; N P Illsley; K M Giacomini
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

4.  Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells.

Authors:  A J Dudley; C D Brown
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  Characterization of guanidine transport in human renal brush border membranes.

Authors:  J K Chun; L Zhang; M Piquette-Miller; E Lau; L Q Tong; K M Giacomini
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

6.  Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush border membrane vesicles from human kidney.

Authors:  C M Brett; C B Washington; R J Ott; M M Gutierrez; K M Giacomini
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

7.  Membrane transporters in drug disposition.

Authors:  K M Giacomini
Journal:  J Pharmacokinet Biopharm       Date:  1997-12

8.  Stereoselective interactions of organic cations with the organic cation transporter in OK cells.

Authors:  R J Ott; K M Giacomini
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

9.  pH-dependent transport of procainamide in cultured renal epithelial monolayers of OK cells: consistent with nonionic diffusion.

Authors:  A J Dudley; C D Brown
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Luminal transport system for H+/organic cations in the rat proximal tubule. Kinetics, dependence on pH; specificity as compared with the contraluminal organic cation-transport system.

Authors:  C David; G Rumrich; K J Ullrich
Journal:  Pflugers Arch       Date:  1995-08       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.